Filter posts

How Can We Control Drug Costs While Supporting Innovation?

As the debate on drug pricing continues, our elected leaders will almost certainly adopt policies …

BIO’s Hans Sauer Calls for Less Confusing Patent Eligibility Standards

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, recently testified at the second of …

Licensing of Research Has Had Huge Impact on Economy & Jobs

A new report from BIO and AUTM demonstrates to enormous return on investment that ultimately …

Setting the Record Straight on March-In Rights

In a recent piece for The Washington Post, author Christopher Rowland inaccurately suggested that the federal government …

When Intervention Stifles Innovation

Dr. Gregory Dolin of the Center for Medicine and Law at the University of Baltimore …

Happy 91st Birthday Senator Bayh!

At its best, government enables citizens to flourish socially and economically. Above and beyond the …

USMCA Paves the Way for Biotech Innovation

After more than a year of high-stakes drama, the U.S. has inked an updated trade …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

Bipartisan SUCCESS Act is Good for American Innovation

Last week, the House Judiciary Committee unanimously reported the bipartisan SUCCESS Act. Co-sponsored by Representatives …

New Documentary Highlights Consequences of Bad Patent Laws

The U.S. leads the world in biotech innovation, delivering solutions to combat debilitating and rare …